Synergia

Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022

Retrieved on: 
Tuesday, February 1, 2022

Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022.

Key Points: 
  • Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022.
  • We deliver highly satisfactory results for 2021, and I am proud to say that we expect continued, solid performance in 2022.
  • Novozymes is built for growth and we have a strong foundation to accelerate our future performance.
  • Despite continued challenges brought on by the Covid-19 pandemic, Novozymes made solid progress in 2021 and stayed the course to meet all except one of its 2022 targets and long-term commitments.

New (ISC)² Research Reveals the Challenges and Opportunities Associated with Diversity, Equity and Inclusion in the Cybersecurity Community

Retrieved on: 
Monday, October 18, 2021

The study outlines eight recommendations for improving DEI in cybersecurity teams, from implementing cultural sensitivity training to documenting clear advancement practices.

Key Points: 
  • The study outlines eight recommendations for improving DEI in cybersecurity teams, from implementing cultural sensitivity training to documenting clear advancement practices.
  • "What we found is that many issues are universal to the experiences of diverse professionals no matter where they live and work.
  • Following is a small selection of the respondents' firsthand accounts and advice in the report:
    "The diversity of thought is a global crisis.
  • I mean, it needs to be in the cybersecurity workforce or else nothing's going to be secure in this world."